Company news
Avecho Biotechnology Limited news in 2021
Avecho Biotechnology Limited's news releases, calls and decks from 2021, newest first.
AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
December 20, 2021
Positive results from Avechos Phase I trial of CBD soft-gel
December 7, 2021
September 2021 Quarterly Activities Report & Appendix 4C
October 28, 2021
Topical CBD pain study with Lambert Initiative approved
October 20, 2021
Dosing begins in Phase I PK trial testing CBD soft-gel
October 3, 2021
Phase I clinical trial testing CBD product-enrolment begins
September 14, 2021
June 2021 Quarterly Activities Report & Appendix 4C
July 26, 2021
Avecho to Present New CBD Data at GCI Virtual Summit
June 8, 2021
Chairs Address and CEO Presentation
May 31, 2021
AB Vista to explore new TPM applications for Animal Health
May 30, 2021
TGA meeting for CBD soft-gel targeting insomnia
May 25, 2021
Avecho completes pharmaceutical CBD soft-gel product
May 20, 2021
March 2021 Quarterly Activities Report & Appendix 4C
April 28, 2021
Avecho receives ethics approval for CBD human trial
April 12, 2021
AVE receives firm commitment to raise $5.06 via placement
February 9, 2021
December 2020 Quarterly Activities Report & Appendix 4C
January 29, 2021
Decks in 2021
- Shareholder Meeting (May 2021)
Shareholder meeting · 23 slides · May 31, 2021
- Investor Presentation (January 2021)
Investor deck · 27 slides · January 2021